Genmab | Rörelsekostnader



Operating Expenses Ändra Datum
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Almirall EUR 195.38M 68.92M 2024-06
Amarin USD 67.47M 549K 2024-09
Amgen USD 6.86B 85M 2025-03
argenx SE USD 635.37M 62.66M 2024-12
AstraZeneca USD 9.91B 2.94B 2025-03
Bayer EUR 8.2B 5.59B 2024-12
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Demant DKK 9B 4.47B 2024-12
Exelixis USD 403.55M 82K 2025-01
Fresenius Medical Care EUR 4.55B 275.89M 2025-03
Galapagos EUR 233.68M 95.46M 2025-03
Genmab DKK 4.25B 812M 2024-12
GlaxoSmithKline GBP 5.3B 2.12B 2025-03
GN Store Nord DKK 3.77B 547M 2025-03
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Insmed USD 334.86M 28M 2024-12
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 8.32B 1.55B 2025-03
UCB EUR 1.23B 1.31B 2024-06



Genmab Rörelsekostnader - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.